[1]王钦君,张红春,申娴娟,等.MicroRNAs作为结直肠癌潜在标记物的研究进展[J].现代检验医学杂志,2015,30(04):107-110.[doi:10.3969/j.issn.1671-7414.2015.04.031]
　WANG Qin-jun,ZHANG Hong-chun,SHEN Xian-juan,et al.MicroRNAs as a Potential Marker in the Progress of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2015,30(04):107-110.[doi:10.3969/j.issn.1671-7414.2015.04.031]
点击复制

MicroRNAs作为结直肠癌潜在标记物的研究进展()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年04期
页码:
107-110
栏目:
综述
出版日期:
2015-08-10

文章信息/Info

Title:
MicroRNAs as a Potential Marker in the Progress of Colorectal Cancer
文章编号:
1671-7414(2015)04-107-05
作者:
王钦君1; 2; 张红春2; 申娴娟1; 鞠少卿1
1.南通大学附属医院外科综合实验室, 江苏南通 226001;
2.启东市人民医院检验科,江苏启东 226200
Author(s):
WANG Qin-jun1; 2; ZHANG Hong-chun2; SHEN Xian-juan1; JU Shao-qing1
1.Surgical Comprehensive Laboratory,Affiliated Hospital of Nantong University, Jiangsu Nantong 226001,China;
2.Department of Clinical Laboratory, Qidong People's Hospital,Jiangsu Qidong 226200,China
关键词:
微小RNA;  结直肠癌;  生物学标志物;  靶点
分类号:
R735.3; R730.43
DOI:
10.3969/j.issn.1671-7414.2015.04.031
文献标志码:
A
摘要:
微小RNA(miRNAs)是一种非编码的内源性RNA分子,miRNAs 的异常表达与疾病,尤其与恶性肿瘤的发生、发展存在密切的关系。研究证明,miRNAs可以作为结直肠癌(colorectal cancer,CRC)早期诊断、治疗、预后的新的分子生物学标志物,同时,miRNAs可作为体内CRC治疗的靶点。该文旨在对与CRC相关的miRNAs的表达、功能、作用机制、靶基因等及其在临床应用前景等方面作一综述。
Abstract:
MicroRNAs(miRNAs)are small,non-coding RNAs that regulate the translation of specific protein coding genes.Recent studies have revealed the role of miRNAs in a variety of basic biological and pathologicalprocesses.Previous studies have suggested miRNAs can be servered as a new tumor biomarker in the early diagnosis,treatment and assessment of prognosis of CRC,which also can be servered as the treatment target in vivo of CRC patients.This paper reviews the expression and targets of miRNAs,its mechanism of the development and prospect in clinical application in CRC.

参考文献/References:

[1] Siegel R,Naishadham D,Jemal A.Cancer statistics,2013[J].CACancer J Clin,2013,63(1):11-30.
[2] 刘寒梢,马越云,肖华胜.血清微小RNA(miR-129-3p,miR-767-3p和miR-877)在结直肠癌诊断中的价值[J].肿瘤,2012,32(1):42-48.
Liu HS,Ma YY,Xiao HS.The diagnostic value of serum microRNA including miR-129-3p,miR-767-3p and miR-877 for colorectal cancer[J].Cancer,2012,32(1):42-48.
[3] Ji DB,Li M,Zhan TC,et al.Prognostic role of serum AZGP1,PEDF and PRDX2 in colorectal cancer patients[J].Carcinogenesis,2013,34(6):1265-1272.
[4] Chendrimada TP,Gregory RI,Kumaraswamy E,et al.TRBP recruits the dicercomplex to Ago2 for microRNA processing and gene silencing[J].Nature,2005,436(7051):740-744.
[5] Kim Y,Kim VN.MicroRNA factory:RISC assembly from precursor microRNAs[J].Molecular Cell,2012,46(4):384-386.
[6] Nagel R,Le Sage C,Diosdado B,et al.Regulation of the adenomatous polyposis coil gene by the miR-135 family in colorectal cancer[J].Cancer Res,2008,68(14):5795-5802.
[7] Mishra PJ,Song B,Mishra PJ,et al.MiR-24 tumor suppressor activity isregulated independent of p53 and through a target site polymorphism[J].PLoSOne,2009,4(12):e8445.
[8] Luo XY,Burwinkel B,Tao S,et al.MicroRNA signatures: novel biomarkerfor colorectal cancer?[J].Cancer Epidemiol Biomarker Prev,2011,20(7):1272-1286.
[9] Wu J,Ji XW,Zhu LL,et al.Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells[J].Cancer Lett,2013,329(2):155-163.
[10] Zhou XJ,Dong ZG,Yang YM,et al.Limited diagnostic value of microRNAs for detecting colorectal cancer:a meta-analysis[J].Asian Pac J Cancer Prev,2013,14(8):4699-4704.
[11] Li YJ,Zhang ZY,Mao YY,et al.A genetic variant in MiR-146a modifiesdigestive system cancer risk:a meta-analysis[J].Asian Pac J Cancer Prev,2014,15(1):145-150.
[12] Ng EK,Chang WW,Jin H,et al.Differential expression of microRNAs in plasma of patients with colorectal cancer:a potential marker for colorectal cancer screening[J].Gut,2009,58(10):1375-1381.
[13] 邱 实,孟凡旭,刘 念,等.miRNA-21在结直肠癌中的表达研究[J].中国实验诊断学,2014,18(1):91-93.
Qiu S,Meng FX,Liu N,et al.The expression of microRNA-21 in colorectalcancer[J].Chinese Journal of Laboratory Diagnosis,2014,18(1):91-93.
[14] 张 媛,林贞花,金铁峰,等.结直肠癌中miRNAs差异表达谱的筛查[J].世界华人消化杂志,2014,22(30):4578-4587.
Zhang Y,Lin ZH,Jin TF,et al.MicroRNA expression profile in colorectalcancer[J].World Chinese Journal of Digestology,2014,22(30):4578-4587.
[15] Lee JK,Liles EG,Bent S,et al.Accuracy of fecal immunochemical testsfor colorectal cancer:systematic review and meta-analysis[J].Ann Intern Med,2014,160(3):171.
[16] Link A,Balaguer F,Shen Y,et al.FecaI microRNAs as novel biomarkers for colon cancer screening[J].Cancer Epidemiol Biomaerkers Prev,2010,19(7):1766-1774.
[17] Wu CW,Ng SS,Dong YJ,et al.Detection of miR- 92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps[J].Gut,2012,61(5):739-745.
[18] Koga Y,Yasunaga M,Takahashi A,et al.MicroRNA expression profiling ofexfoliated colonocytes isolated from feces for colorectal cancer screening[J].Cancer Prev Res(Phila),2010,3(11):1435-1442.
[19] Lombardi L,Morelli F,Cinieri S,et al.Adjuvant colon cancer chemotherapy: where we are and where we'll go[J].Cancer Treat Rev,2010,36(Suppl 3):S34-S41.
[20] Zheng KY,Liu WC,Liu Y,et al.MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1[J].Oncol Lett,2015,9(2):869-874.
[21] 廖信芳,李正荣,杨清水,等.microRNA-139-5p及其靶基因Notch1在结直肠癌中的作用[J].中国普通外科杂志,2014,23(10):1373-1378.
Liao XF,Lin ZR,Yang QS,et al.Role of microRNA-139-5p and its target gene Notch1 in colorectal cancer[J].Chinese Journal of General Surgery,2014,23(10):1373-1378.
[22] Pizzini S,Bisognin A,Mandruzzato S,et al.Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and developmentof metastasis[J].BMC Genomics,2013(14):589.
[23] Wang LG,Gu J.Serum microRNA-29a is a promising novel marker for earlydetection of colorectal liver metastasis[J].Cancer Epidemiol,2012,36(1):e61-e67.
[24] Xu K,Liu XB,Mao XB,et al.MicroRNA-149 suppresses colorectal cancercell migration and invasion by directly targeting forkhead box transcription factor FOXM1[J].Cell Physiol Biochem,2015,35(2):499-515.
[25] Nishida N,Yamashita S,Mimori K,et al.MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-Fluorouracil in colorectal cancer cells[J].Ann Surq Oncol,2012,19(9):3065-3071.
[26] Nishimura J,Handa R,Yamamoto H,et al.microRNA-181a is associated with poor prognosis of colorectal cancer[J].Oncology Reports,2012,28(6):2221-2226.
[27] Hur K,Toiyama Y,Schetter AJ,et al.Identification of a metastasis-specific microRNA signature in human colorectal cancer[J].J Natl Cancer Inst,2015,107(3):492.
[28] Gao Y,Liu YM,Du LT,et al.Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior[J].Med Oncol,2015,32(1):362.
[29] Shivapurkar N,Weiner LM,Marshall JL,et al.Recurrence of early stagecolon cancer predicted by expression pattern of circulation microRNAs[J].PLOSOne,2014,9(1):e84686.
[30] Yuan DW,Li K,Zhu K,et al.Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer[J].Cancer Biol Ther,2015,16(2):268-275.
[31] 李慧慧,宋 宝,王哲海.结直肠癌miRNA相关基因单核苷酸多态性与预后相关性研究现状[J].中华肿瘤防治杂志,2014,21(1):77-80.
Li HH,Song B,Wang ZH.Corrleation between SNP within miRNA related genesand prognosis of colorectal cancer[J].Chinese J Cancer Prev Treat,2014,21(1):77-80.
[32] Pichler M,Winter E,Ress AL,et al.miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor[J].J Clin Pathol,2014,67(3):198-203.
[33] Cappuzzo F,Sacconi A,Landi L,et al.MicroRNA signature in metastaticcolorectal cancer patients treated with anti-EGFR monoclonal antibodies[J].Clin Colorectal Cancer,2014,13(1):37-45.e4.
[34] Toden S,Okugawa Y,Jascur T,et al.Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer[J].Carcinogenesis,2015,36(3):355-367.
[35] Kjersem JB,Ikdahl T,Lingjaerde OC,et al.Plasma microRNAs predictingclinical outcome in metastatic colorectal cancer patients receiving first-lineoxaliplatin-based treatment[J].Mol Oncol,2014,8(1):59-67.
[36] Chen JM,Wang WN,Zhang YD,et al.Predicting distant metastasis and chemoresistance using plasma miRNAs[J].Med Oncol,2014,31(1):799.

相似文献/References:

[1]白盈盈,朱光旭,潘兴华.长链非编码RNA对结直肠癌潜在诊断价值的研究进展[J].现代检验医学杂志,2018,33(01):161.[doi:10.3969/j.issn.1671-7414.2018.01.001]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金面上项目(项目编号:81271920),国家自然科学基金青年基金(项目编号:81301498),江苏省“科技兴卫工程”创兴团队项目(项目编号:LJ201133)。
作者简介:王钦君(1985-),女,在读硕士研究生,主管技师,主要从事临床生化与分子生物学检验,Tel:13962820366,E-mail:190482321@qq.com。
通讯作者:鞠少卿(1963-),男,博士,主任技师,主要从事临床生化与分子生物学检验,E-mail:jsq814@hotmail.com。
更新日期/Last Update: 2015-08-10